Literature DB >> 24488783

Descriptive profile of β-thalassemia mutations in West Bengal population: a hospital-based study.

Deboshree M Bhattacharyya1, Ashis Mukhopadhyay, Jayasri Basak.   

Abstract

The present study was based in a hospital at which 660 individuals have been screened for thalassemia in the past 4 years. The main purposes of the study were to identify different types of beta mutations prevailing among these patients, and to establish a genotype-phenotypic correlation. Complete blood count, high-performance liquid chromatography, and amplification refractory mutation system-based polymerase chain reaction were performed on peripheral blood samples to detect beta mutations. Of the 660 subjects studied, 380 (57.6 %) were male and 280 (42.4 %) were female. These included 258 (39.09 %) normal individuals, 176 (26.67 %) β-thalassemia carriers, 44 (6.67 %) β-thalassemia major, 6 (0.91 %) cases of sickle β-thalassemia, 6 (0.91 %) carriers of sickle cell anemia, 102 (15.45 %) Hb Eβ-thalassemia, 42 (6.36 %) HbE carriers, 16 (2.42 %) HbE homozygous, and 10 (1.52 %) carriers of other mutations. Genotypic study of beta mutations revealed the prevalence of IVS1-5 mutation among the studied beta carriers to be 46.6 %, and codon 26 (G>A) mutation to be 31.54 %. Other prevailing mutations among the screened individuals include codon 30 (7.53 %), codon 15 (5.01 %), codon 41/42 (3.58 %), and codon 8/9 (1.07 %). Genotype-phenotype correlation revealed that the phenotype of the above-mentioned mutations is associated with mild, moderate, and severe forms of thalassemia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488783     DOI: 10.1007/s12185-014-1511-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  33 in total

1.  Prevention of thalassemia: a necessity in India.

Authors:  I C Verma; V P Choudhry; P K Jain
Journal:  Indian J Pediatr       Date:  1992 Nov-Dec       Impact factor: 1.967

2.  The molecular basis of thalassaemia major and thalassaemia intermedia in Asian Indians: application to prenatal diagnosis.

Authors:  S L Thein; C Hesketh; R B Wallace; D J Weatherall
Journal:  Br J Haematol       Date:  1988-10       Impact factor: 6.998

Review 3.  Molecular basis and prenatal diagnosis of beta-thalassemia.

Authors:  H H Kazazian; C D Boehm
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

Review 4.  Genetic modifiers of beta-thalassemia.

Authors:  Swee Lay Thein
Journal:  Haematologica       Date:  2005-05       Impact factor: 9.941

5.  Characterization of beta-thalassaemia mutations in 57 beta-thalassaemia families seen at Lucknow.

Authors:  S Agarwal; M Naveed; U R Gupta; P Kishore; S S Agarwal
Journal:  Indian J Med Res       Date:  1994-09       Impact factor: 2.375

6.  Sickle cell-beta+ thalassaemia in Orissa State, India.

Authors:  A E Kulozik; S Bail; B C Kar; B E Serjeant; G E Serjeant
Journal:  Br J Haematol       Date:  1991-02       Impact factor: 6.998

7.  Inherited haemoglobin disorders: an increasing global health problem.

Authors:  D J Weatherall; J B Clegg
Journal:  Bull World Health Organ       Date:  2001-10-24       Impact factor: 9.408

8.  Interaction of different hemoglobinopathies in Eastern India with a view to establish genotype-phenotype correlation.

Authors:  Swapan Kumar Das; Madhusnata De; Dilip Kumar Bhattacharya; Bani Sengupta; Nikhilesh Das; Geeta Talukder
Journal:  Am J Hum Biol       Date:  2000-07       Impact factor: 1.937

9.  Spectrum of beta-thalassemia mutations and their association with allelic sequence polymorphisms at the beta-globin gene cluster in an Eastern Indian population.

Authors:  Ritushree Kukreti; Debasis Dash; Vineetha K E; Sanchita Chakravarty; Swapan Kr Das; Madhusnata De; Geeta Talukder
Journal:  Am J Hematol       Date:  2002-08       Impact factor: 10.047

10.  An abundant erythroid protein that stabilizes free alpha-haemoglobin.

Authors:  Anthony J Kihm; Yi Kong; Wei Hong; J Eric Russell; Susan Rouda; Kazuhiko Adachi; M Celeste Simon; Gerd A Blobel; Mitchell J Weiss
Journal:  Nature       Date:  2002-06-13       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.